Efficacy of ChemoID® guided drug selection for palliative chemotherapy in advanced recurrent high-grade ovarian adenocarcinoma: Case study. Transl Med Rep [Internet]. 2017 Oct. 13 [cited 2026 May 14];2(1). Available from: https://www.pagepressjournals.org/tmr/article/view/6701